Nektar Therapeutics Capital Expenditures
Nektar Therapeutics (NKTR) reported Capital Expenditures of $112.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- Nektar Therapeutics payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $94.00K, a 154.05% increase year-over-year.
- Nektar Therapeutics payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $18.00K, a 800.00% increase year-over-year.
- Nektar Therapeutics payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $18.00K, a 96.08% decline year-over-year.
- Nektar Therapeutics payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $114.00K, a 82.88% decline year-over-year.
- Nektar Therapeutics payments to acquire property, plant, and equipment for fiscal 2025 was $171.00K, a 88.35% decline from fiscal 2024.
- Nektar Therapeutics payments to acquire property, plant, and equipment for fiscal 2024 was $1.47M, a 69.71% increase from fiscal 2023.
- Nektar Therapeutics payments to acquire property, plant, and equipment for fiscal 2023 was $865.00K, a 84.76% decline from fiscal 2022.
- Nektar Therapeutics payments to acquire property, plant, and equipment for fiscal 2022 was $5.68M, a 62.13% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $112.00K 10-Q · filed 2026-08-14 | $130.00K derived: sum of 3 quarters · filed 2026-08-14 | $244.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-08 | $36.00K derived: sum of 2 quarters · filed 2026-05-08 | $150.00K derived: sum of 3 quarters · filed 2026-05-08 | $187.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $132.00K derived: sum of 2 quarters · filed 2026-03-13 | $169.00K derived: sum of 3 quarters · filed 2026-08-14 | $171.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $151.00K derived: sum of 2 quarters · filed 2026-08-14 | $153.00K 10-Q · filed 2025-11-07 | $612.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $39.00K 10-Q · filed 2026-08-14 | $498.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-08 | $461.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.13M derived: sum of 3 quarters · filed 2026-05-08 | $1.31M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $1.13M derived: sum of 2 quarters · filed 2026-03-13 | $1.31M derived: sum of 3 quarters · filed 2026-03-13 | $1.47M 10-K · filed 2026-03-13 |
| 2024-09-30 | $666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $852.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.01M 10-Q · filed 2025-11-07 | $1.25M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $343.00K 10-Q · filed 2025-08-08 | $580.00K derived: sum of 3 quarters · filed 2025-08-08 | $613.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $157.00K 10-Q · filed 2025-05-09 | $394.00K derived: sum of 2 quarters · filed 2025-05-09 | $427.00K derived: sum of 3 quarters · filed 2025-05-09 | $589.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $270.00K derived: sum of 2 quarters · filed 2025-03-14 | $432.00K derived: sum of 3 quarters · filed 2025-03-14 | $865.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $195.00K derived: sum of 2 quarters · filed 2024-11-08 | $628.00K 10-Q · filed 2024-11-08 | $1.14M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $595.00K 10-Q · filed 2024-08-09 | $1.11M derived: sum of 3 quarters · filed 2024-08-09 | $1.29M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $433.00K 10-Q · filed 2024-05-10 | $945.00K derived: sum of 2 quarters · filed 2024-05-10 | $1.13M derived: sum of 3 quarters · filed 2024-05-10 | $1.91M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $693.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.47M derived: sum of 3 quarters · filed 2024-03-05 | $5.68M 10-K · filed 2024-03-05 |
| 2022-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $961.00K derived: sum of 2 quarters · filed 2023-11-08 | $5.16M 10-Q · filed 2023-11-08 | $11.06M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $780.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.98M 10-Q · filed 2023-08-09 | $10.88M derived: sum of 3 quarters · filed 2024-03-05 | $13.81M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $4.20M 10-Q · filed 2023-05-10 | $10.10M derived: sum of 2 quarters · filed 2024-03-05 | $13.04M derived: sum of 3 quarters · filed 2024-03-05 | $16.32M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $8.83M derived: sum of 2 quarters · filed 2024-03-05 | $12.11M derived: sum of 3 quarters · filed 2024-03-05 | $14.99M 10-K · filed 2024-03-05 |
| 2021-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $6.22M derived: sum of 2 quarters · filed 2022-11-04 | $9.09M 10-Q · filed 2022-11-04 | $10.85M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $6.16M 10-Q · filed 2022-08-05 | $7.91M derived: sum of 3 quarters · filed 2023-02-28 | $9.82M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.88M 10-Q · filed 2022-05-06 | $4.63M derived: sum of 2 quarters · filed 2023-02-28 | $6.54M derived: sum of 3 quarters · filed 2023-02-28 | $9.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.66M derived: sum of 2 quarters · filed 2023-02-28 | $6.36M derived: sum of 3 quarters · filed 2023-02-28 | $7.26M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $4.60M derived: sum of 2 quarters · filed 2021-11-05 | $5.50M 10-Q · filed 2021-11-05 | $9.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.59M 10-Q · filed 2021-08-06 | $7.26M derived: sum of 3 quarters · filed 2022-03-01 | $12.59M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $900.00K 10-Q · filed 2021-05-07 | $4.57M derived: sum of 2 quarters · filed 2022-03-01 | $9.89M derived: sum of 3 quarters · filed 2022-03-01 | $21.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.99M derived: sum of 2 quarters · filed 2022-03-01 | $20.64M derived: sum of 3 quarters · filed 2022-03-01 | $26.29M 10-K · filed 2022-03-01 |
| 2019-09-30 | $5.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $16.97M derived: sum of 2 quarters · filed 2020-11-06 | $22.61M 10-Q · filed 2020-11-06 | $31.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $11.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $17.29M 10-Q · filed 2020-08-07 | $25.98M derived: sum of 3 quarters · filed 2021-02-26 | $27.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $5.65M 10-Q · filed 2020-05-08 | $14.34M derived: sum of 2 quarters · filed 2021-02-26 | $16.16M derived: sum of 3 quarters · filed 2021-02-26 | $18.90M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $10.51M derived: sum of 2 quarters · filed 2021-02-26 | $13.25M derived: sum of 3 quarters · filed 2021-02-26 | $14.24M 10-K · filed 2021-02-26 |
| 2018-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.57M derived: sum of 2 quarters · filed 2019-11-07 | $5.55M 10-Q · filed 2019-11-07 | $7.95M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $3.73M 10-Q · filed 2019-08-09 | $6.12M derived: sum of 3 quarters · filed 2020-02-28 | $7.06M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $985.00K 10-Q · filed 2019-05-09 | $3.38M derived: sum of 2 quarters · filed 2020-02-28 | $4.32M derived: sum of 3 quarters · filed 2020-02-28 | $6.57M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.33M derived: sum of 2 quarters · filed 2020-02-28 | $5.59M derived: sum of 3 quarters · filed 2020-02-28 | $9.68M 10-K · filed 2020-02-28 |
| 2017-09-30 | $939.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.19M derived: sum of 2 quarters · filed 2018-11-08 | $7.28M 10-Q · filed 2018-11-08 | $9.93M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $6.34M 10-Q · filed 2018-08-09 | $8.99M derived: sum of 3 quarters · filed 2019-03-01 | $9.50M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $4.09M 10-Q · filed 2018-05-10 | $6.74M derived: sum of 2 quarters · filed 2019-03-01 | $7.25M derived: sum of 3 quarters · filed 2019-03-01 | $8.80M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.16M derived: sum of 2 quarters · filed 2019-03-01 | $4.71M derived: sum of 3 quarters · filed 2019-03-01 | $6.39M 10-K · filed 2019-03-01 |
| 2016-09-30 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.06M derived: sum of 2 quarters · filed 2017-11-08 | $3.74M 10-Q · filed 2017-11-08 | $6.21M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.23M 10-Q · filed 2017-08-09 | $5.71M derived: sum of 3 quarters · filed 2018-03-01 | $9.85M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $1.68M 10-Q · filed 2017-05-10 | $4.15M derived: sum of 2 quarters · filed 2018-03-01 | $8.29M derived: sum of 3 quarters · filed 2018-03-01 | $11.81M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $6.61M derived: sum of 2 quarters · filed 2018-03-01 | $10.14M derived: sum of 3 quarters · filed 2018-03-01 | $11.20M 10-K · filed 2018-03-01 |
| 2015-09-30 | $4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $7.66M derived: sum of 2 quarters · filed 2016-11-04 | $8.72M 10-Q · filed 2016-11-04 | $12.61M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $4.58M 10-Q · filed 2016-08-04 | $8.47M derived: sum of 3 quarters · filed 2017-03-01 | $9.37M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.06M 10-Q · filed 2016-05-04 | $4.95M derived: sum of 2 quarters · filed 2017-03-01 | $5.84M derived: sum of 3 quarters · filed 2017-03-01 | $6.51M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.78M derived: sum of 2 quarters · filed 2017-03-01 | $5.45M derived: sum of 3 quarters · filed 2017-03-01 | $9.98M 10-K · filed 2017-03-01 |
| 2014-09-30 | $898.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.57M derived: sum of 2 quarters · filed 2015-11-06 | $6.09M 10-Q · filed 2015-11-06 | $8.80M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $668.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $5.19M 10-Q · filed 2015-08-06 | $7.90M derived: sum of 3 quarters · filed 2016-02-29 | $8.49M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $4.52M 10-Q · filed 2015-05-01 | $7.23M derived: sum of 2 quarters · filed 2016-02-29 | $7.82M derived: sum of 3 quarters · filed 2016-02-29 | $8.30M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.30M derived: sum of 2 quarters · filed 2016-02-29 | $3.77M derived: sum of 3 quarters · filed 2016-02-29 | $4.09M 10-K · filed 2016-02-29 |
| 2013-09-30 | $588.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.07M derived: sum of 2 quarters · filed 2014-11-07 | $1.38M 10-Q · filed 2014-11-07 | $6.22M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $794.00K 10-Q · filed 2014-08-01 | $5.63M derived: sum of 3 quarters · filed 2015-02-26 | $8.21M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $316.00K 10-Q · filed 2014-05-08 | $5.16M derived: sum of 2 quarters · filed 2015-02-26 | $7.73M derived: sum of 3 quarters · filed 2015-02-26 | $9.38M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $7.41M derived: sum of 2 quarters · filed 2015-02-26 | $9.07M derived: sum of 3 quarters · filed 2015-02-26 | $10.58M 10-K · filed 2015-02-26 |
| 2012-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $4.23M derived: sum of 2 quarters · filed 2013-11-07 | $5.74M 10-Q · filed 2013-11-07 | $7.17M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.17M 10-Q · filed 2013-08-09 | $4.60M derived: sum of 3 quarters · filed 2014-02-27 | $6.05M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $1.52M 10-Q · filed 2013-05-09 | $2.94M derived: sum of 2 quarters · filed 2014-02-27 | $4.39M derived: sum of 3 quarters · filed 2014-02-27 | $7.47M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $2.88M derived: sum of 2 quarters · filed 2014-02-27 | $5.96M derived: sum of 3 quarters · filed 2014-02-27 | $9.72M 10-K · filed 2014-02-27 |
| 2011-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $4.53M derived: sum of 2 quarters · filed 2012-11-09 | $8.29M 10-Q · filed 2012-11-09 | $17.59M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $6.84M 10-Q · filed 2012-08-09 | $16.14M derived: sum of 3 quarters · filed 2013-03-01 | $29.51M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $3.77M 10-Q · filed 2012-05-04 | $13.06M derived: sum of 2 quarters · filed 2013-03-01 | $26.43M derived: sum of 3 quarters · filed 2013-03-01 | $31.25M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $22.66M derived: sum of 2 quarters · filed 2013-03-01 | $27.48M derived: sum of 3 quarters · filed 2013-03-01 | $31.46M 10-K · filed 2013-03-01 |
| 2010-09-30 | $13.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $18.19M derived: sum of 2 quarters · filed 2011-11-04 | $22.16M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $8.80M 10-Q · filed 2011-08-05 | ||
| 2010-03-31 | $3.97M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $16.39M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |